<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39333962</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Predicting malignant potential of solitary pulmonary nodules in patients with COVID-19 infection: a comprehensive analysis of CT imaging and tumor markers.</ArticleTitle><Pagination><StartPage>1050</StartPage><MedlinePgn>1050</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1050</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09952-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To analyze the value of combining computed tomography (CT) with serum tumor markers in the differential diagnosis of benign and malignant solitary pulmonary nodules (SPNs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The case data of 267 patients diagnosed with SPNs in the First Affiliated Hospital of Zhengzhou University from March 2020 to January 2023 were retrospectively analyzed. All individuals diagnosed with coronavirus disease 2019 (COVID-19) were confirmed via respiratory specimen viral nucleic acid testing. The included cases underwent CT, serum tumor marker testing and pathological examination. The diagnostic efficacy and clinical significance of CT, serum tumor marker testing and a combined test in identifying benign and malignant SPNs were analyzed using pathological histological findings as the gold standard. Finally, a nomogram mathematical model was established to predict the malignant probability of SPNs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 267 patients with SPNs, 91 patients were not afflicted with COVID-19, 36 exhibited malignant characteristics, whereas 55 demonstrated benign features. Conversely, within the cohort of 176 COVID-19 patients presenting with SPNs, 62 were identified as having malignant SPNs, and the remaining 114 were diagnosed with benign SPNs. CT scans revealed statistically significant differences between the benign and malignant SPNs groups in terms of CT values (P&lt;0.001), maximum nodule diameter (P&lt;0.001), vascular convergence sign (P&lt;0.001), vacuole sign (P = 0.0007), air bronchogram sign (P = 0.0005), and lobulation sign (P = 0.0005). Malignant SPNs were associated with significantly higher levels of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) compared to benign SPNs (P &lt; 0.05), while no significant difference was found in carbohydrate antigen 125 (CA125) levels (P = 0.054 for non-COVID-19; P = 0.072 for COVID-19). The sensitivity (95.83%), specificity (95.32%), and accuracy (95.51%) of the comprehensive diagnosis combining serum tumor markers and CT were significantly higher than those of CT alone (70.45%, 79.89%, 76.78%) or serum tumor marker testing alone (56.52%, 73.71%, 67.79%) (P &lt; 0.05). A visual nomogram predictive model for malignant pulmonary nodules was constructed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Combining CT with testing for CEA, CA125, and NSE levels offers high diagnostic accuracy and sensitivity, enables precise differentiation between benign and malignant nodules, particularly in the context of COVID-19, thereby reducing the risk of unnecessary surgical interventions.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xiao</LastName><ForeName>Huijuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Yihe</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency, the First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zheng zhou, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Pan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yonggao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Jianbo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. gjb_1232022@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003074" MajorTopicYN="Y">Solitary Pulmonary Nodule</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="Y">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">CT</Keyword><Keyword MajorTopicYN="N">Diagnostic efficacy</Keyword><Keyword MajorTopicYN="N">Nomogram</Keyword><Keyword MajorTopicYN="N">Solitary pulmonary nodules</Keyword><Keyword MajorTopicYN="N">Tumor markers</Keyword></KeywordList><CoiStatement>The authors declare no competing interests. The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39333962</ArticleId><ArticleId IdType="pmc">PMC11430562</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09952-3</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09952-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alazwari S, Alsamri J, Asiri MM, Maashi M, Asklany SA, Mahmud A. Computer-aided diagnosis for lung cancer using waterwheel plant algorithm with deep learning. Sci Rep. 2024;14:20647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11375088</ArticleId><ArticleId IdType="pubmed">39232180</ArticleId></ArticleIdList></Reference><Reference><Citation>Albano D, Gatta R, Marini M, Rodella C, Camoni L, Dondi F et al. Role of (18)F-FDG PET/CT Radiomics Features in the Differential diagnosis of Solitary Pulmonary nodules: diagnostic accuracy and comparison between two different PET/CT scanners. J Clin Med. 2021; 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8584460</ArticleId><ArticleId IdType="pubmed">34768584</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolopoulos ID, Pintelas EG, Livieris IE, Apostolopoulos DJ, Papathanasiou ND, Pintelas PE, et al. Automatic classification of solitary pulmonary nodules in PET/CT imaging employing transfer learning techniques. Med Biol Eng Comput. 2021;59:1299–310.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003394</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Jiang X, Hong Y, Wen Z, Wei S, Peng G, et al. Can chest CT features distinguish patients with negative from those with positive initial RT-PCR results for Coronavirus Disease (COVID-19)? AJR Am J Roentgenol. 2021;216:66–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">32368928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejardin D, Kraxner A, Schindler E, Städler N, Wolbers M. An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapies. Front Immunol. 2024;15:1351584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11371698</ArticleId><ArticleId IdType="pubmed">39234243</ArticleId></ArticleIdList></Reference><Reference><Citation>Du S, Gao S, Huang G, Li S, Chong W, Jia Z, et al. Chest lesion CT radiological features and quantitative analysis in RT-PCR turned negative and clinical symptoms resolved COVID-19 patients. Quant Imag Med Surg. 2020;10:1307–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276361</ArticleId><ArticleId IdType="pubmed">32550139</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Shi M, Chen S, Ju G, Chen L, Lu H, et al. Analysis of serum cfDNA concentration and integrity before and after surgery in patients with lung cancer. Cell Mol Biol. 2019;65:56–63.</Citation><ArticleIdList><ArticleId IdType="pubmed">31472048</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu B, Hu L, Lv F, Huang J, Li W, Ouyang Y, et al. Follow-up ct results of covid-19 patients with initial negative chest CT. Infect Drug Resist. 2020;13:2681–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422692</ArticleId><ArticleId IdType="pubmed">32821132</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenn LM, Troy LK, Corte TJ. Novel diagnostic techniques in interstitial lung disease. Front Med. 2023;10:1174443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10175799</ArticleId><ArticleId IdType="pubmed">37188089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasymjanova G, Rizzolo A, Pepe C, Friedmann JE, Small D, Spicer J, et al. The impact of COVID-19 on the diagnosis and treatment of lung cancer over a 2-year period at a Canadian academic center. Curr Oncol. 2022;29:8677–85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9689557</ArticleId><ArticleId IdType="pubmed">36421337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JS, Hao EI, Rho SY, Hwang HK, Lee WJ, Yoon DS et al. Clinical pattern of preoperative positron emission tomography/computed tomography (PET/CT) can predict the aggressive behavior of resected solid pseudopapillary neoplasm of the pancreas. Cancers. 2021; 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8125428</ArticleId><ArticleId IdType="pubmed">33925678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwee TC, Kwee RM. Chest CT in COVID-19: what the Radiologist needs to know. Radiographics. 2020;40:1848–65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7587296</ArticleId><ArticleId IdType="pubmed">33095680</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KS, Wi YM. Residual lung lesions at 1-year CT after COVID-19. Radiology. 2022;302:720–1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515203</ArticleId><ArticleId IdType="pubmed">34609154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Sung C, Lee HS, Yoon HY, Kim SJ, Oh JS, et al. Is (18)F-FDG PET/CT useful for the differential diagnosis of solitary pulmonary nodules in patients with idiopathic pulmonary fibrosis? Ann Nucl Med. 2018;32:492–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29974372</ArticleId></ArticleIdList></Reference><Reference><Citation>MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, et al. Guidelines for management of Incidental Pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017;284:228–43.</Citation><ArticleIdList><ArticleId IdType="pubmed">28240562</ArticleId></ArticleIdList></Reference><Reference><Citation>Niyonkuru A, Chen X, Bakari KH, Wimalarathne DN, Bouhari A, Arnous MMR, et al. Evaluation of the diagnostic efficacy of (18) F-Fluorine-2-Deoxy-D-Glucose PET/CT for lung cancer and pulmonary tuberculosis in a tuberculosis-endemic country. Cancer Med. 2020;9:931–42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6997090</ArticleId><ArticleId IdType="pubmed">31837121</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahk K, Chung JH, Kim S, Lee SH. Predictive value of dual-time (18)F-FDG PET/CT to distinguish primary lung and metastatic adenocarcinoma in solitary pulmonary nodule. Tumori. 2018;104:207–12.</Citation><ArticleIdList><ArticleId IdType="pubmed">29714664</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KS, Seon HJ, Yun JS, Yoo SW, Lee C, Kang SR, et al. Precise characterization of a solitary pulmonary nodule using tumor shadow disappearance rate-corrected F-18 FDG PET and enhanced CT. Medicine. 2022;101:e28764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812657</ArticleId><ArticleId IdType="pubmed">35119036</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden AC, Boland JM, Johnson TF, Aubry MC, Lo YC, Butt YM, et al. Late complications of COVID-19. Arch Pathol Lab Med. 2022;146:791–804.</Citation><ArticleIdList><ArticleId IdType="pubmed">35319744</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa MEE, Matos MJR, Furtado R, Brito VM, Amaral LTW, Beraldo GL, et al. COVID-19 findings identified in chest computed tomography: a pictorial essay. Einstein. 2020;18:eRW5741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7342047</ArticleId><ArticleId IdType="pubmed">32578687</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadhukhan P, Ugurlu MT, Hoque MO. Effect of COVID-19 on lungs: focusing on prospective malignant phenotypes. Cancers. 2020;12:3822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7766284</ArticleId><ArticleId IdType="pubmed">33352869</ArticleId></ArticleIdList></Reference><Reference><Citation>Salihoğlu YS, Uslu Erdemir R, Aydur Püren B, Özdemir S, Uyulan Ç, Ergüzel TT, et al. Diagnostic performance of machine learning models based on (18)F-FDG PET/CT Radiomic features in the classification of Solitary Pulmonary nodules. Mol Imaging Radionucl Ther. 2022;31:82–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9246312</ArticleId><ArticleId IdType="pubmed">35770958</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Y, Yin X, Zhao N, Wang J, Yang S. Comparison of serum tumor markers combined with dual-source CT in the diagnosis of lung cancer. Minerva Med. 2023;114:795–801.</Citation><ArticleIdList><ArticleId IdType="pubmed">33764713</ArticleId></ArticleIdList></Reference><Reference><Citation>Snoeckx A, Reyntiens P, Desbuquoit D, Spinhoven MJ, Van Schil PE, van Meerbeeck JP, et al. Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology. Insights Imaging. 2018;9:73–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5825309</ArticleId><ArticleId IdType="pubmed">29143191</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of Post-acute Lung complications of COVID-19. Radiology. 2021;301:E383–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369881</ArticleId><ArticleId IdType="pubmed">34374591</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadafora M, Pace L, Evangelista L, Mansi L, Del Prete F, Saladini G, et al. Risk-related (18)F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial. Eur J Nucl Med Mol Imaging. 2018;45:1908–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">29730697</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadafora M, Evangelista L, Fiordoro S, Porcaro F, Sicignano M, Mansi L. The multicenter Italian trial assesses the performance of FDG-PET /CT related to pre-test cancer risk in patients with solitary pulmonary nodules and introduces a segmental thoracic diagnostic strategy. Curr Radiopharm. 2020;13:243–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206189</ArticleId><ArticleId IdType="pubmed">32186274</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang K, Wang L, Lin J, Zheng X, Wu Y. The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules. Medicine. 2019;98:e14813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6426628</ArticleId><ArticleId IdType="pubmed">30882661</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentin B, Steuwe A, Wienemann T, Andree M, Keitel V, Ljimani A, et al. CT findings in patients with COVID-19-compatible symptoms but initially negative qPCR test. RoFo. 2022;194:1110–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35545100</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, Su J, Yang K, Wei J, Wan H, Cao X, et al. Elevations of serum cancer biomarkers correlate with severity of COVID-19. J Med Virol. 2020;92:2036–41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267262</ArticleId><ArticleId IdType="pubmed">32347972</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir-McCall JR, Harris S, Miles KA, Qureshi NR, Rintoul RC, Dizdarevic S, et al. Impact of solitary pulmonary nodule size on qualitative and quantitative assessment using 18F-fluorodeoxyglucose PET/CT: the SPUTNIK trial. Eur. J Nucl Med Mol Imaging. 2021;48:1560–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113131</ArticleId><ArticleId IdType="pubmed">33130961</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Wang Q, Liu Q, Zhang Q, Huang Q, Yu Z. The serum tumor markers in combination for clinical diagnosis of lung cancer. Clin Lab. 2020; 66.</Citation><ArticleIdList><ArticleId IdType="pubmed">32162867</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu XY, Ding F, Li K, Huang WC, Zhang Y, Zhu J. Analysis of the causes of solitary pulmonary nodule misdiagnosed as lung cancer by using artificial intelligence: a retrospective study at a single center. Diagnostics. 2022;12:2218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9497679</ArticleId><ArticleId IdType="pubmed">36140618</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia T, Li J, Gao J, Xu X. Small Solitary Ground-Glass nodule on CT as an initial manifestation of Coronavirus Disease 2019 (COVID-19) pneumonia. Korean J Radiol. 2020;21:545–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7183840</ArticleId><ArticleId IdType="pubmed">32323499</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, Zhang P, Wu R, Lu K, Zhou H. Identifying the best marker combination in CEA, CA125, CY211, NSE, and SCC for lung cancer screening by combining roc curve and logistic regression analyses: is it feasible? Disease markers. 2018; 2018: 2082840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6188592</ArticleId><ArticleId IdType="pubmed">30364165</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, Zhang B, Zou H, Shi Y, Cheng L, Zhang Y et al. Multivariate analysis on development of lung adenocarcinoma lesion from solitary pulmonary nodule. Contrast Media Mol Imaging. 2022; 2022: 8330111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9155859</ArticleId><ArticleId IdType="pubmed">35795880</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Jiang XJ, Liu XH, Ma H, Zhang YH, Rao Y, et al. Chest computed tomography (CT) findings and semiquantitative scoring of 60 patients with coronavirus disease 2019 (COVID-19): a retrospective imaging analysis combining anatomy and pathology. PLoS ONE. 2020;15:e0238760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473568</ArticleId><ArticleId IdType="pubmed">32886711</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Huang J, Zou Q, Che J, Yang K, Fan Q, et al. Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer. Oncol Lett. 2020;19:3229–38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7074558</ArticleId><ArticleId IdType="pubmed">32256818</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol. 2020;214:1072–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32125873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariyasingha NM, Chowdhury MRH, Samoilenko A, Salnikov OG, Chukanov NV, Kovtunova LM, et al. Toward Lung Ventilation Imaging using Hyperpolarized Diethyl Ether gas contrast Agent. Chemistry. 2024;30(25):e202304071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11065616</ArticleId><ArticleId IdType="pubmed">38381807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariyasingha NM, Samoilenko A, Chowdhury MRH, Nantogma S, Oladun C, Birchall JR, et al. Developing hyperpolarized butane gas for Ventilation Lung Imaging. Chem Biomed Imaging. 2024. 10.1021/cbmi.4c00041.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>